COMMUNIQUÉS West-GlobeNewswire

VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth
24/07/2026
ZURICH, SWITZERLAND , July 24, 2026 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in the design and development of next-generation cancer therapeutics, held an Extraordinary General [...]
HorseFil Official Launch 2026 Effective Men's Energy and Vitality Gummies Highlights Ingredient, Supplement Facts Available in USA
24/07/2026
HorseFil is a men's dietary supplement formulated with a blend of carefully selected botanical extracts, amino acids, vitamins, and minerals designed to support men's overall wellness. According to the manufacturer, the [...]
Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD
24/07/2026
Landmark FDA Approval Is an Important Milestone in Retina Care, Bringing Patients and Physicians an Ophthalmic Bevacizumab Developed Specifically for the Eye Following Years of Rigorous Clinical and Regulatory [...]
Affidea accélère sa croissance au Royaume-Uni en signant un partenariat stratégique avec LIPS Healthcare
24/07/2026
LONDRES, 24 juill. 2026 (GLOBE NEWSWIRE) -- Affidea, prestataire paneuropéen de cliniques de proximité, de diagnostics de pointe et de services de santé privés spécialisés, annonce aujourd’hui la signature d’un [...]
Nordic Naturals Releases Expert Insights on Why Omega-3s Should Be on Back-to-School Checklists
24/07/2026
Company highlights the important role omega-3s play in children's brain development and cognitive function as they head back to the classroom Watsonville, CA, July 24, 2026 (GLOBE NEWSWIRE) -- Nordic Naturals, the #1 [...]
Ondra Health Names Every Pharmacy That Fills Its GLP-1 Prescriptions, a Disclosure Most Telehealth Platforms Don't Make
24/07/2026
Patients are told to verify their provider before starting GLP-1 treatment. The Los Angeles-based platform publishes its five licensed compounding pharmacies, the prescribing medical group, and full pricing so that [...]
Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction
24/07/2026
Represents significant milestone in the Company’s ongoing portfolio optimization efforts BRENTWOOD, Tenn., July 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a [...]
CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD)
24/07/2026
Susvimo is the first and only continuous delivery treatment that offers an alternative to standard of care eye injections for nAMD Positive recommendation is based on data from the LADDER, Archway and Portal studies [...]
Treace to Report Second Quarter 2026 Financial Results on August 7, 2026
24/07/2026
PONTE VEDRA, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
hear.com Honored as Gold Stevie® Award Winner in 2026 Stevie Awards for Technology Excellence
24/07/2026
Award recognizes Horizon IX hearing aids and Clinic-in-a-Box® tele-audiology for expanding access to hearing care nationwide MIAMI, July 24, 2026 (GLOBE NEWSWIRE) -- hear.com , a global innovator in hearing care, has [...]
Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan
24/07/2026
NEW YORK and SYDNEY, July 24, 2026 (GLOBE NEWSWIRE) -- Radiopharm Theranostics Limited (ASX: RAD, Nasdaq: RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative [...]
MannKind Announces $50 Million Private Placement
24/07/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 24, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient [...]
Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026
24/07/2026
SYDNEY, AUSTRALIA, July 24, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announced [...]
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET
24/07/2026
PRINCETON, N.J., July 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the Company will release its second quarter 2026 financial results on Friday, August [...]
Asimov Joins the Genesis Mission, Using Boston University's NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models
24/07/2026
Asimov will help build out protein production and characterization capabilities at Boston University's AI-programmable cloud laboratory, one of 20 nodes in the new NSF national network. Asimov will use these [...]
Amwell® to report second quarter 2026 operating results
24/07/2026
BOSTON, July 24, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2026 operating results [...]
Persica Pharmaceuticals presents new analyses of microbiology assay sensitivity and intradiscal antibiotic exposure response in chronic Low Back Pain at ASPN 2026 Annual Conference
24/07/2026
Poster presentation builds on Phase 1b PP353 data published in The Lancet's eClinicalMedicine, reinforcing the rationale for a targeted, non-opioid approach to chronic Low Back Pain with Modic changes London, UK, 24 [...]
Dyadic Announces Continued Listing on the Nasdaq Capital Market
24/07/2026
JUPITER, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) (“Dyadic” or the “Company”), d/b/a Dyadic Applied BioSolutions, a biotechnology company developing recombinant protein solutions [...]
NEZGLYAL® (leriglitazone) receives a positive CHMP opinion for the treatment of cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease
24/07/2026
Recommendation based on NEXUS data; Minoryx and Neuraxpharm expect European Commission approval by the end of this quarter BARCELONA, Spain and DÜSSELDORF, Germany, July 24, 2026 (GLOBE NEWSWIRE) -- Minoryx Therapeutics [...]

Pages